Press Releases
AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis
AbbVie , a research-based global biopharmaceutical company, announced that it has submitted applications for a new indication to the U.S. FDA and European Medicines...
Press Releases
Daiichi Sankyo and Syneos Health Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline
Daiichi Sankyo, Inc. announced that it has entered into a strategic agreement with Syneos Health The companies are coming together to form a coalition...
News
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. announced an expansion of their existing collaboration to provide Regeneron with rights to develop products for additional...
Clinical Trials
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment
Junshi Biosciences , a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology...
News
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), announced results...
News
LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials
LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has...
Clinical Trials
Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans
Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.
This investigational...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read